Vancomycin (INN) (IPA: ) is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. It has traditionally been reserved as a drug of "last resort", used only after treatment with other antibiotics had failed, although the emergence of vancomycin-resistant organisms means that it is increasingly being displaced from this role by linezolid and the carbapenems.
It was developed by Eli Lilly, which marketed vancomycin hydrochloride under the trade name Vancocin. In 2004, Eli Lilly licensed Vancocin to ViroPharma in the U.S., Flynn Pharma in the UK and Aspen Pharmacare in Australia. The patent expired in the early 1980s and generic versions of the drug are also available under various trade names.
Antibiotics :: Drugs and Medications

Vancomycin - Familydoctor.org - Information for patients in English and Spanish.
| Nutrition Part III: Probiotics | |
| Next Video | |